Longfa Kou

5.0k total citations · 2 hit papers
109 papers, 4.0k citations indexed

About

Longfa Kou is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Longfa Kou has authored 109 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 27 papers in Biomaterials and 20 papers in Oncology. Recurrent topics in Longfa Kou's work include Nanoparticle-Based Drug Delivery (22 papers), Nanoplatforms for cancer theranostics (15 papers) and Drug Transport and Resistance Mechanisms (12 papers). Longfa Kou is often cited by papers focused on Nanoparticle-Based Drug Delivery (22 papers), Nanoplatforms for cancer theranostics (15 papers) and Drug Transport and Resistance Mechanisms (12 papers). Longfa Kou collaborates with scholars based in China, United States and New Zealand. Longfa Kou's co-authors include Qing Yao, Jin Sun, Zhonggui He, Ruijie Chen, Yinglei Zhai, Ying‐Zheng Zhao, Vadivel Ganapathy, Helin Xu, Lin Zhu and Ying Tu and has published in prestigious journals such as Biochemical Journal, Chemical Engineering Journal and ACS Applied Materials & Interfaces.

In The Last Decade

Longfa Kou

103 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The endocytosis and intracellular fate of nanomedicines: Implication for rational design

2013 470 citations Longfa Kou, Jin Sun et al. Asian Journal of Pharmaceutical Sciences profile →
Metabolic reprogramming of macrophages by a nano-sized opsonization strategy to restore M1/M2 balance for osteoarthritis therapy

2025 19 citations Ruijie Chen, Huirong Huang et al. Journal of Controlled Release profile →

Peers

Countries citing papers authored by Longfa Kou

Since Specialization

Citations

This map shows the geographic impact of Longfa Kou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longfa Kou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longfa Kou more than expected).

Fields of papers citing papers by Longfa Kou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longfa Kou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longfa Kou. The network helps show where Longfa Kou may publish in the future.

Co-authorship network of co-authors of Longfa Kou

This figure shows the co-authorship network connecting the top 25 collaborators of Longfa Kou. A scholar is included among the top collaborators of Longfa Kou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longfa Kou. Longfa Kou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adaptive bilirubin nanoscavenger alleviates pulmonary oxidative stress and inflammation for acute lung injury therapy 2025 ·Journal of Advanced Research ·Longfa Kou, (unknown), Shize Li, (unknown), Di Huang, (unknown), (unknown), (unknown), (unknown), Yuqi Yan, (unknown), Wanling Zhu, Xianbao Shi, Hailin Zhang, Ruijie Chen	3
2	Simultaneous targeting of multiple etiological using a nanosized strategy for psoriasis management 2025 ·Materials Today Bio ·Xinyu Jiang, Minghui Wang, Linyi Zhang, Zhiyi Huang, Pengfei Mao, Yingyi Zhao, (unknown), Yuqi Han, Lei Cai, (unknown), (unknown), (unknown), (unknown), Ruijie Chen, Longfa Kou	1
3	A biomimetic liposome platform targeting non-small cell lung cancer to modulate the inflammatory and metabolic microenvironment for enhanced therapy 2025 ·Chemical Engineering Journal ·Xinyu Jiang, Pengfei Mao, Minghui Wang, Dan Shen, Linyi Zhang, Yingyi Zhao, Xiao Liang, Zhiyi Huang, Yunzhi Wang, (unknown), (unknown), Yuqi Han, (unknown), (unknown), Congying Xie, Ruijie Chen, Longfa Kou	0
4	α-methyltryptophan-mediated protection against diabetic nephropathy in db/db mice as studied with a metabolomics approach 2025 ·Frontiers in Pharmacology ·Aimin Cai, Dan Shen, (unknown), Jie Ding, Yangyang Ding, (unknown), Lijia Chen, Qing Yao, (unknown), Ruijie Chen, Vadivel Ganapathy, Longfa Kou	1
5	Opsonization Inveigles Macrophages Engulfing Carrier‐Free Bilirubin/JPH203 Nanoparticles to Suppress Inflammation for Osteoarthritis Therapy 2024 ·Advanced Science ·Huirong Huang, (unknown), (unknown), (unknown), Shengjie Li, Pengfei Mao, (unknown), Yahui Chen, Lining Sun, (unknown), Aimin Cai, Luhui Wang, Huixiang Sheng, Qing Yao, Ruijie Chen, Ying‐Zheng Zhao, Longfa Kou	36
6	Chondrocyte-targeted bilirubin/rapamycin carrier-free nanoparticles alleviate oxidative stress and modulate autophagy for osteoarthritis therapy 2024 ·Journal of Controlled Release ·Huirong Huang, (unknown), Shengjie Li, Yuqi Yan, Shize Li, Chenyu Qiu, (unknown), Yixuan Zhu, Dan Shen, (unknown), Luhui Wang, Nuo Chen, (unknown), (unknown), Fu‐Gen Wu, Xianbao Shi, Longfa Kou, Ruijie Chen, Qing Yao	13
7	Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome 2024 ·Colloids and Surfaces B Biointerfaces ·(unknown), (unknown), Qian Wang, (unknown), Longfa Kou, Hailin Zhang	19
8	Supramolecular nanoparticle loaded with bilirubin enhances cartilage protection and alleviates osteoarthritis via modulating oxidative stress and inflammatory responses 2024 ·Colloids and Surfaces B Biointerfaces ·(unknown), Huirong Huang, Xinyu Jiang, (unknown), Chenyu Qiu, (unknown), (unknown), Yunzhi Wang, Yuqi Yan, (unknown), (unknown), Wanling Zhu, Fu‐Gen Wu, Xianbao Shi, Ruijie Chen, Longfa Kou	5
9	Bilirubin/morin self-assembled nanoparticle-engulfed collagen/polyvinyl alcohol hydrogel accelerates chronic diabetic wound healing by modulating inflammation and ameliorating oxidative stress 2024 ·International Journal of Biological Macromolecules ·Ying‐Zheng Zhao, (unknown), (unknown), Di Huang, (unknown), Yifan Shi, (unknown), Ying Zhang, Yueyue Fu, Yi Chen, Longfa Kou, Qing Yao	23
10	Ultraviolet B radiation-induced JPH203-loaded keratinocyte extracellular vesicles exert etiological interventions for psoriasis therapy 2023 ·Journal of Controlled Release ·Xinyu Jiang, Zewei Jiang, Shuqi Huang, Pengfei Mao, Linyi Zhang, Minghui Wang, (unknown), Lining Sun, Meng Sun, Ruijie Lu, (unknown), Huixiang Sheng, (unknown), Aimin Cai, (unknown), Qing Yao, (unknown), Ruijie Chen, Longfa Kou	15
11	Fe-involved nanostructures act as photothermal transduction agents in cancer photothermal therapy 2023 ·Colloids and Surfaces B Biointerfaces ·Zewei Jiang, (unknown), (unknown), (unknown), Qing Yao, Ruijie Chen, Longfa Kou	15
12	Water-responsive gel extends drug retention and facilitates skin penetration for curcumin topical delivery against psoriasis 2023 ·Asian Journal of Pharmaceutical Sciences ·Qing Yao, Yuanyuan Zhai, (unknown), Qian Wang, Lining Sun, (unknown), (unknown), (unknown), (unknown), (unknown), Ruijie Chen, Hailin Zhang, Xiang Luo, Longfa Kou	29
13	Hyaluronic acid coated bilirubin nanoparticles attenuate ischemia reperfusion-induced acute kidney injury 2021 ·Journal of Controlled Release ·Zhiwei Huang, Yannan Shi, Yuanyuan Zhai, (unknown), (unknown), (unknown), Longfa Kou, Jian Xiao, Ying‐Zheng Zhao, Qing Yao	83
14	Protective effects and mechanisms of bilirubin nanomedicine against acute pancreatitis 2020 ·Journal of Controlled Release ·Qing Yao, Xue Jiang, Yuanyuan Zhai, Lan-Zi Luo, Helin Xu, Jian Xiao, Longfa Kou, Ying‐Zheng Zhao	65
15	The role of transporters in cancer redox homeostasis and cross-talk with nanomedicines 2020 ·Asian Journal of Pharmaceutical Sciences ·Longfa Kou, Xinyu Jiang, Huirong Huang, (unknown), (unknown), Qing Yao, Ruijie Chen	35
16	Nanoparticle mediated codelivery of nifuratel and doxorubicin for synergistic anticancer therapy through STAT3 inhibition 2020 ·Colloids and Surfaces B Biointerfaces ·Hailun Zheng, Zhiwei Chen, Aimin Cai, (unknown), Xinyu Jiang, Bin Zhou, Jun Wang, Qing Yao, Ruijie Chen, Longfa Kou	30
17	Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy 2019 ·Drug Delivery ·Longfa Kou, Shuyi Xiao, Rui Sun, Shihui Bao, Qing Yao, Ruijie Chen	91
18	Tumor-targeted drug delivery and sensitization by MMP2-responsive polymeric micelles 2019 ·Nanomedicine Nanotechnology Biology and Medicine ·Qing Yao, Yin Liu, Longfa Kou, Ying Tu, Xing Tang, Lin Zhu	55
19	Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types 2018 ·Frontiers in Pharmacology ·Longfa Kou, Yangzom D. Bhutia, Qing Yao, Zhonggui He, Jin Sun, Vadivel Ganapathy	243
20	Enhanced Oral Delivery of Paclitaxel Using Acetylcysteine Functionalized Chitosan-Vitamin E Succinate Nanomicelles Based on a Mucus Bioadhesion and Penetration Mechanism 2013 ·Molecular Pharmaceutics ·He Lian, Tianhong Zhang, Jin Sun, Xiaohong Liu, Guolian Ren, Longfa Kou, Youxi Zhang, Xiaopeng Han, Wenya Ding, Xiaoyu Ai, Chunnuan Wu, Lin Li, Yongjun Wang, Yinghua Sun, Siling Wang, Zhonggui He	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact